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Summary. The molecular changes associated with the 
transition of melanoma cells from radial growth phase to 
vertical growth phase (metastatic phenotype) are not 
well defined. Our recent studies have demonstrated that 
the two tumor suppressor genes, p53 and p16/CDKN2, 
do not play a major role in the acquisition of the 
metastatic phenotype in human melanoma. Mutations in 
p53 are infrequent and do not correlate with the 
metastatic potential of human melanoma cells while 
p161CDKN2 abnormalities are frequent, but are not pre- 
requisite for the acquistion of the metastatic phenotype. 
On the other hand, the tyrosine-kinase receptor c-KIT 
and the cell adhesion molecule MCAMIMUC-18 play 
active roles in the progression of human melanoma. 
Metastatic melanoma cells overexpress MCAM and do 
not express the c-KIT receptor. Enforced c-KIT 
expression in metastatic cells significantly inhibited their 
growth and metastatic potential in nude mice. 
Furthermore, exposure of c-KIT-positive melanoma cells 
in vitro and in vivo to stem cell factor (SCF), the ligand 
for c-KIT, triggered apoptosis of these cells but not of 
normal melanocytes. Ectopic expression of MCAM into 
primary cutaneous melanoma cells enhanced their 
tumorigenicity and met$static ability in vivo. We found 
that both genes, c-KIT and MCAM, are regulated by the 
transcription factor AP-2 and that metastatic melanoma 
cells do not express AP-2. We therefore propose that loss 
of AP-2 might be a crucial event in the progression of 
human melanoma. 
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Introduction 
Malignant melanoma is a common human cancer 
with high mortality rates. The incidence of this disease is 
currently increasing faster than any other malignancy. 
The primary cause of melanoma is thought to be UVR 
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exposure (Fountain et al., 1990). Other risk factors 
include fair skin, a hereditary predisposition toward the 
disease, increased age and race (Rhodes et al., 1987). In 
the Caucasian population, for example, it is increasing 
rapidly and is projected to be about 1 in 75 by the turn of 
the century (Ahmed, 1997). The steady overall rise has 
been attributed to various causes ranging from the 
reduction of the stratospheric ozone to the changing 
lifestyles and attitudes that affect sun exposure 
(Frederick and Shell, 1988; Kerr, 1988; McPhail, 1997). 
Although it is easily diagnosed and wholly curable if 
detected early, the high mortality rate (6,700 deaths/yr. 
in the USA) is due to the propensity for melanoma to 
metastatize if left untreated (Dooley, 1994). 
Most human malignant melanomas develop as a 
consequence of a lengthy multistep process. This process 
involves formation of nevi from normal melanocytes, a 
radial growth phase and a subsequent vertical growth 
phase (metastatic phenotype, see Fig. 1) which results in 
decreased dependence on growth factors, reduction of 
contact inhibition and diminished anchorage dependence 
(Lu and Kerbel, 1994). The prevalent working model for 
melanoma metastasis development defines it as a series 
of interrelated, sequential steps involving the survival 
and growth of unique subpopulations of cells with 
metastatic properties that preexisted within the parental 
neoplasm (Fidler, 1990). 
Cytogenetic studies have shown that human 
melanomas contain a number of frequent chromosomal 
abnormalities which include translocations, partial 
deletions or losses that most frequently involve 
chromosomes lp, 6p, 6q, 7q, 9p, 10q and l lq .  Some of 
these chromosomal alterations are associated with loss 
of heterozygosity which strongly indicates that tumor 
suppressor genes may be present (Fountain et al., 1990). 
In fact, chromosomal mapping studies eventually led to 
the identification of the melanoma susceptibility gene, 
p161CDKN2 (Kamb et al., 1994). 
The molecular steps leading to human malignant 
melanoma and subsequent metastasis are not well 
known. Speculation is that they are reminiscent of other 
more well-defined cancer types like human colorectal 
cancer that is found to be the result of the cumulative 
effect of a series of dominant and recessive mutations 
(Fearon and Vogelstein, 1990; Lu and Kerbel, 1994). 






